Teresa Lagergård
#152,216
Most Influential Person Now
Polish medical researcher
Teresa Lagergård's AcademicInfluence.com Rankings
Teresa Lagergårdlaw Degrees
Law
#3262
World Rank
#4102
Historical Rank
Common Law
#216
World Rank
#234
Historical Rank
International Law
#1419
World Rank
#1692
Historical Rank
Download Badge
Law
Teresa Lagergård's Degrees
- Bachelors Medicine Medical University of Warsaw
- Masters Medical Research Medical University of Warsaw
- PhD Medical Sciences Medical University of Warsaw
Why Is Teresa Lagergård Influential?
(Suggest an Edit or Addition)According to Wikipedia, Teresa Lagergård was born 1946 in Sosnowiec, Poland. She is professor emerita at University of Gothenburg, Sahlgrenska Academy, Institute of Biomedicine, Department of Microbiology and Immunology.
Teresa Lagergård's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A placebo-controlled trial of a pertussis-toxoid vaccine. (1995) (277)
- Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina (1997) (270)
- A diffusible cytotoxin of Haemophilus ducreyi. (1997) (225)
- Inhibition of Attachment of Streptococcus pneumoniae and Haemophilus influenzae by Human Milk and Receptor Oligosaccharides (1986) (204)
- Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides. (1983) (188)
- Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. (2000) (179)
- Inhibition of attachment of Streptococcus pneumoniae and Haemophilus influenzae by human milk and receptor oligosaccharides. (1986) (171)
- Multilocus Sequence Typing of Swedish Invasive Group B Streptococcus Isolates Indicates a Neonatally Associated Genetic Lineage and Capsule Switching (2005) (170)
- Etiology of community‐acquired pneumonia in children based on antibody responses to bacterial and viral antigens (1989) (168)
- Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma. (1984) (141)
- The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell-cycle arrest in the G2 phase. (1999) (129)
- GroEL Heat Shock Protein of Haemophilus ducreyi: Association with Cell Surface and Capacity To Bind to Eukaryotic Cells (1998) (121)
- Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. (1991) (119)
- Cellular Internalization of Cytolethal Distending Toxin from Haemophilus ducreyi (2000) (113)
- Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children. (1988) (106)
- Evaluation of PCR for Diagnosis of Bordetella pertussis and Bordetella parapertussisInfections (1998) (95)
- Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons. (2001) (89)
- Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate. (1989) (88)
- Haemophilus ducreyi, a cytotoxin-producing bacterium (1992) (86)
- Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin. (2005) (85)
- The role of different protein components from the Haemophilus ducreyi cytolethal distending toxin in the generation of cell toxicity. (2001) (83)
- Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid (1990) (77)
- Prevalence of cdtABC genes encoding cytolethal distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains. (2001) (71)
- Etiology of Genital Ulcer Disease and Association With Human Immunodeficiency Virus Infection in Two Tanzanian Cities (2003) (71)
- Difference in structure between type b and nontypable Haemophilus influenzae populations (1986) (68)
- Characterization of a Haemophilus ducreyi Mutant Deficient in Expression of Cytolethal Distending Toxin (1999) (66)
- Systemic and Mucosal Immune Responses in Mice after Mucosal Immunization with Group B Streptococcus Type III Capsular Polysaccharide-Cholera Toxin B Subunit Conjugate Vaccine (2000) (66)
- Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates (1995) (61)
- A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned (1996) (56)
- Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses. (1999) (56)
- Mortality and morbidity from invasive bacterial infections during a clinical trial of acellular pertussis vaccines in Sweden. (1988) (56)
- Induction of apoptosis/necrosis in various human cell lineages by Haemophilus ducreyi cytolethal distending toxin. (2005) (54)
- The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid. (1992) (52)
- Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants. (1997) (51)
- Toxicity and immunogenicity of purified Haemophilus ducreyi cytolethal distending toxin in a rabbit model. (2002) (47)
- Serotypes and clinical manifestations of group B streptococcal infections in western Sweden. (2000) (47)
- The impact of Haemophilus ducreyi cytolethal distending toxin on cells involved in immune response. (2001) (45)
- Etiology of community-acquired pneumonia in out-patients (1986) (45)
- Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate (1997) (43)
- Immunization of children with pertussis toxoid decreases spread of pertussis within the family. (1998) (43)
- Purification and identification of Haemophilus ducreyi cytotoxin by use of a neutralizing monoclonal antibody (1997) (42)
- Application of multilocus enzyme gel electrophoresis to Haemophilus influenzae (1986) (41)
- Evidence of Haemophilus ducreyi adherence to and cytotoxin destruction of human epithelial cells. (1993) (41)
- Incidence and prognosis of acute epiglottitis in children in a Swedish region. (1984) (41)
- Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis. (1995) (40)
- How common is whooping cough in a nonvaccinating country? (1993) (39)
- Interactions of Haemophilus ducreyi and purified cytolethal distending toxin with human monocyte-derived dendritic cells, macrophages and CD4+ T cells. (2004) (37)
- Cytolethal distending toxin upregulates RANKL expression in Jurkat T‐cells (2008) (37)
- Prevention of invasive bacterial diseases by immunization with polysaccharide-protein conjugates. (1989) (35)
- Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization. (2000) (34)
- Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine (2011) (34)
- Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age. (1991) (34)
- Aetiology of acute epiglottitis in adults. (1998) (34)
- Synthesis of a conjugate vaccine composed of pneumococcus type 14 capsular polysaccharide bound to pertussis toxin (1992) (34)
- Etiology of community-acquired pneumonia in patients requiring hospitalization (1985) (33)
- Parapertussis infection followed by pertussis infection (1994) (33)
- Neutralizing antibodies to Haemophilus ducreyi cytotoxin (1993) (33)
- Molecular Characterization of Haemophilus ducreyi Isolates from Different Geographical Locations (2006) (31)
- Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine. (2001) (31)
- Vaccination of infants with a four-dose and a three-dose vaccination schedule. (1999) (31)
- Group B Streptococcus Capsular Polysaccharide-Cholera Toxin B Subunit Conjugate Vaccines Prepared by Different Methods for Intranasal Immunization (2001) (28)
- Characterization of the serum antibody response to the capsular polysaccharide of Haemophilus influenzae type b in children with invasive infections. (1992) (27)
- Immunogenicity and safety of a pertussis vaccine composed of pertussis toxin inactivated by hydrogen peroxide, in 18- to 23-month-old children. (1990) (25)
- The cytolethal distending toxin of Haemophilus ducreyi aggravates dermal lesions in a rabbit model of chancroid. (2005) (25)
- Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussis. (1997) (25)
- Safety, immunogenicity and an open, retrospective study of efficacy of a monocomponent pertussis toxoid vaccine in infants. (1994) (25)
- Cytotoxin production in 100 strains of Haemophilus ducreyi from different geographic locations. (1995) (25)
- Nature of cross-reactivity between Haemophilus influenzae types a and b and Streptococcus pneumoniae types 6A and 6B. (1983) (25)
- Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate. (2001) (24)
- Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi. (1995) (24)
- Immunogenicity and reactogenicity of diphtheria, tetanus and pertussis toxoids combined with inactivated polio vaccine, when administered concomitantly with or as a diluent for a Hib conjugate vaccine. (2001) (23)
- Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose (2005) (23)
- Structurally defined epitopes of Haemophilus ducreyi lipooligosaccharides recognized by monoclonal antibodies (1997) (23)
- Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old children. (1990) (23)
- Specificity of antibodies directed against the cytolethal distending toxin of Haemophilus ducreyi in patients with chancroid. (2003) (22)
- The Cytolethal Distending Toxin of Haemophilus ducreyi Inhibits Endothelial Cell Proliferation (2002) (22)
- Antibodies against Haemophilus influenzae type b and tetanus in infants after subcutaneous vaccination with PRP-T/diphtheria, or PRP-OMP/diphtheria-tetanus vaccines. (1994) (22)
- Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis. (1999) (21)
- Binding of Haemophilus ducreyi to carbohydrate receptors is mediated by the 58.5-kDa GroEL heat shock protein. (2006) (21)
- Serum Immunoglobulin G Antibody Responses to Bordetella pertussis Lipooligosaccharide and B.parapertussis Lipopolysaccharide in Children with Pertussis and Parapertussis (2001) (20)
- Mature Glycoprotein G Presents High Performance in Diagnosing Herpes Simplex Virus Type 2 Infection in Sera of Different Tanzanian Cohorts (2006) (20)
- Comparison between radioimmunoassay and direct and indirect enzyme-linked immunosorbent assays for determination of antibodies against Haemophilus influenzae type b capsular polysaccharide (1988) (19)
- Low milk IgA antibody to Haemophilus influenzae colonising nasopharynx of infants (1990) (18)
- Immunoglobulin A antibodies to pertussis toxin and filamentous hemagglutinin in saliva from patients with pertussis (1990) (18)
- Haemophilus ducreyi: pathogenesis and protective immunity. (1995) (18)
- Antibody response to outer membrane of noncapsulated Haemophilus influenzae isolated from the nasopharynx of children with pneumonia (1991) (17)
- Subclass compositions of immunoglobulin G to pertussis toxin in patients with whooping cough, in healthy individuals, and in recipients of a pertussis toxoid vaccine (1989) (16)
- Development of serum antibodies of the immunoglobulin G class and subclasses against the capsular polysaccharide of Haemophilus influenzae type b in children and adults with invasive infections (1988) (16)
- Cytotoxin production in 100 strains of from different geographic locations (1995) (16)
- Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk (1992) (16)
- Serum antibodies against a 69-kilodalton outer-membrane protein, pertactin, from Bordetella pertussis in nonvaccinated children with and without a history of clinical pertussis. (1992) (15)
- Serum antibodies against haemophilus influenzae type b and tetanus at 2.5 years of age: a follow-up of 2 different regimens of infant vaccination. (1996) (15)
- Formaldehyde treatment increases the immunogenicity and decreases the toxicity of Haemophilus ducreyi cytolethal distending toxin. (2007) (14)
- Distribution of Chlamydia trachomatis ompA genovars and the new variant of C. trachomatis in the Göteborg area, Sweden (2010) (14)
- In Vitro and In Vivo Interactions of Haemophilusducreyi with Host Phagocytes (2002) (14)
- An enzyme-linked-immunosorbent assay method for detection of immunoglobulins to pertussis toxin. (2009) (13)
- Determination of neutralizing antibodies and specific immunoglobulin isotype levels in infants after vaccination against diphtheria (1992) (13)
- ANTIBODIES AGAINST HAEMOPHILUS INFLUENZAE TYPE b CAPSULAR POLYSACCHARIDE AND TETANUS TOXOID BEFORE AND AFTER A BOOSTER DOSE OF THE CARRIER PROTEIN NINE YEARS AFTER PRIMARY VACCINATION WITH A PROTEIN CONJUGATE VACCINE (2005) (13)
- Incidence, predisposing factors and manifestations of invasiveHaemophilus influenzae infections in adults (1984) (13)
- Seroprevalences of Herpes Simplex Virus Type 2, Five Oncogenic Human Papillomaviruses, and Chlamydia trachomatis in Katowice, Poland (2008) (12)
- REDUCED IMMUNOGENICITY OF DIPHTHERIA AND TETANUS TOXOIDS WHEN COMBINED WITH PERTUSSIS TOXOID (2005) (12)
- Antibodies to group B streptococci in neonates and infants (1998) (12)
- Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi. (1998) (11)
- Monoclonal antibodies againstHaemophilus ducreyi lipooligosaccharide and their diagnostic usefulness (1995) (11)
- Antibody responses to capsular polysaccharide, lipopolysaccharide, and outer membrane in adults infected with Haemophilus influenzae type b (1984) (11)
- Serum antibody response to capsular polysaccharide, outer membrane, and lipooligosaccharide in children with invasive Haemophilus influenzae type b infections (1987) (11)
- Aetiology of Acute Epiglottitis in Adults (1998) (10)
- On the evolution of the sexually transmitted bacteria Haemophilus ducreyi and Klebsiella granulomatis (2011) (10)
- Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assay (1988) (9)
- The evolution of infectious agents in relation to sex in animals and humans: brief discussions of some individual organisms (2011) (8)
- Characterization of mechanisms involved in adherence of Haemophilus ducreyi to eukaryotic cells (1998) (8)
- Localisation and immunological properties of a 24-kDa surface protein of Haemophilus ducreyi. (1995) (8)
- Determination of pertactin IgG antibodies for the diagnosis of pertussis. (2003) (8)
- Acquisition of serum antibodies against filamentous hemagglutinin and pertactin unrelated to Bordetella pertussis infection (1999) (7)
- Detoxified Haemophilus ducreyi cytolethal distending toxin and induction of toxin specific antibodies in the genital tract. (2010) (7)
- Serum antibody response to filamentous hemagglutinin in patients with clinical pertussis measured by an enzyme-linked immunosorbent assay (1988) (7)
- Rapid diagnosis of pertussis. (1990) (7)
- Standardization of acellular pertussis vaccine by assay of serum neutralizing antibodies to pertussis toxin (antitoxin): analogy with diphtheria toxoid. (1998) (7)
- Prevalence of serum antibodies to human papilloma virus in patients with genital ulcer disease in an urban population of Tanzania (2006) (6)
- Toxic activity of the CdtB component of Haemophilus ducreyi cytolethal distending toxin expressed from an adenovirus 5 vector (2010) (6)
- Immunity to pertussis. Not all virulence factors are protective antigens. (1998) (6)
- Comparison of the Etest with agar dilution for antimicrobial susceptibility testing of Haemophilus ducreyi. (1996) (6)
- Immunogenic and adjuvant properties of Haemophilus ducreyi lipooligosaccharides. (2009) (5)
- Prevalence of antibodies against group B streptococcal capsular polysaccharides in healthy Chinese neonates. (1997) (5)
- Serum antibody responses to nonencapsulated Haemophilus influenzae isolated from the nasopharynx of children with pneumonia. (1992) (4)
- Immunity to Pertussis (1998) (4)
- Method for testing adherence ofHaemophilus influenzae to human buccal epithelial cells (1985) (4)
- EVOLUTION OF INFECTIOUS AGENTS IN RELATION TO SEX (2011) (3)
- [Streptococcus group B--association with Aerobic vaginitis and ability to human cell lines activation]. (2007) (3)
- No cross-reactivity with filamentous hemagglutinin of Bordetella pertussis in sera from patients with nontypable Haemophilus influenzae pneumonia. (1996) (3)
- Serum antibodies to the components of diphtheria-tetanus-pertussis vaccine in Polish children related to vaccination status (1995) (3)
- Protection against pertussis with a monocomponent pertussis toxoid vaccine. (1999) (2)
- Cytolethal distending toxin as virulence factor, protective antigen, and target for vaccine development (2012) (2)
- Antibody levels to pertussis toxin in preschool children in a non-vaccinating country (Sweden). (1986) (1)
- Toxoid vaccine for pertussis (1997) (1)
- Immunologic evaluation of a pertussis toxoid vaccine. (1991) (1)
- TOXOID VACCINE FOR PERTUSSIS. AUTHORS' REPLY (1997) (1)
- Antibody Responses toCapsular Polysaccharide, Lipopolysaccharide, andOuterMembraneinAdults Infected with Haemophilus influenzae Typeb (1984) (0)
- Synthesis ofaConjugate Vaccine Composedof Pneumococcus Type14Capsular Polysaccharide BoundtoPertussis Toxin (1992) (0)
- Monocomponent Pertussis Toxoid Vaccine Immunologic and Epidemiologic Experience of Vaccination With a (2013) (0)
- Vaccination of humans intranasally with cholera toxin B-subunit induces antibody responses in vaginal and nasal secretions as well as in serum (1997) (0)
- Studies on development of vaccines against pathogens causing sexually transmitted infections (2010) (0)
This paper list is powered by the following services:
Other Resources About Teresa Lagergård
What Schools Are Affiliated With Teresa Lagergård?
Teresa Lagergård is affiliated with the following schools:
